Concepedia

Sheri Klas

SK

Statistics

Publications

3

Citations

64

H-Index

3

Active since

2020

Affiliations

Stanford University(Current)

SiteOne Therapeutics (United States)

Sheri Klas is an author at Stanford University specializing in ion channel pharmacology, nociceptive mechanisms, and pain neurobiology.

Publications per year

2020–2024

3

Publications

3

Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain

Jacob T. Beckley, Hassan Pajouhesh, George Luu et al. · Pain · 2020 · 36 citations · Full text

Medicine, Neurobiology, Pharmacology +17

ST‐2560, a selective inhibitor of the Na<sub>V</sub>1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates

John V. Mulcahy, Jacob T. Beckley, Sheri Klas et al. · British Journal of Pharmacology · 2024 · 17 citations · Full text

Medicine, Neurobiology, Pharmacology +17

Discovery of Selective Inhibitors of Na<sub>V</sub>1.7 Templated on Saxitoxin as Therapeutics for Pain

Hassan Pajouhesh, Anton Delwig, Jacob T. Beckley et al. · ACS Medicinal Chemistry Letters · 2022 · 11 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–3 of 3